Additionally, we found increased CD137 expression on circulating Treg of HNSCC patients, which is another marker for enhanced T cell activity and is known to have effects on CD8+ T cell proliferation and survival. The gene discussed is TNFRSF9; the disease is head and neck squamous cell carcinoma.